With 0.65 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.74 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $10.1682 whereas the lowest price it dropped to was $7.34. The 52-week range on NAKA shows that it touched its highest point at $34.77 and its lowest point at $0.65 during that stretch. Beta for the stock currently stands at 34.44.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NAKA was up-trending over the past week, with a rise of 50.71%, but this was down by -28.05% over a month. Three-month performance surged to 153.17% while six-month performance rose 680.59%. The stock gained 671.77% in the past year, while it has gained 525.49% so far this year.
Float and Shares Shorts:
At present, 7.58 million NAKA shares are outstanding with a float of 2.53 million shares on hand for trading. On 2025-07-15, short shares totaled 0.54 million, which was 708.0 higher than short shares on 1749772800. In addition to Mr. Timothy Pickett as the firm’s Founder, CEO & Chairman, Mr. Jared E. Barrera M.B.A. serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.11038 of NAKA’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, NAKA reported revenue of $408527.0 and operating income of -$2391491.0. The EBITDA in the recently reported quarter was -$2312790.0 and diluted EPS was -$0.35.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
